Quarterly report · Q2
3762.TEDINET S100SAO3
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.6bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥13.1bn | 2023-07-01 → 2023-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥46.0bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥20.7bn | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥10.9bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.4bn | 2023-07-01 → 2023-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.9bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.0bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥1.4bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥1.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥1.0bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.4bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥851m | 2023-07-01 → 2023-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥561m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥949m | 2023-07-01 → 2023-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥3.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥682m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥72.5bn | at 2023-09-30 | Cons. | Assets IFRS |
| Total assets | ¥65.7bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥60.8bn | at 2022-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥47.5bn | at 2023-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥41.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥25.0bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥23.9bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥21.8bn | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥20.2bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥20.1bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥19.0bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥17.4bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥22.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥20.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥19.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥18.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.3bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥654m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥3.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥996m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥319m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥35.28 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥21.21 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥73.91 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥26.65 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥14.06 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥35.16 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥21.14 | 2023-07-01 → 2023-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥73.67 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥26.57 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥14.02 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 27.7% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.9% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.6% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥218m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥218m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥86m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥16.5bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥16.4bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥95m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥498m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥24.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥24.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥218m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥175m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥175m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥65m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥81m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥13.5bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥108m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥748m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥20.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥20.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥175m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 878
| Item | Context | Value | Unit |
|---|---|---|---|
| Finance costs IFRS | Prior1YTDDuration | 37219000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 19292000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | -4996000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | -3413000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 1914523000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 2274212000 | JPY |
| Income tax expense IFRS | Prior1YTDDuration | 604279000 | JPY |
| Income tax expense IFRS | CurrentYTDDuration | 688039000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 1310243000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 1586172000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YTDDuration | 1063735000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYTDDuration | 1411779000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1YTDDuration | 246508000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentYTDDuration | 174393000 | JPY |
| Basic earnings loss per share IFRS | Prior1YTDDuration | 26.65 | |
| Basic earnings loss per share IFRS | CurrentYTDDuration | 35.28 | |
| Diluted earnings loss per share IFRS | Prior1YTDDuration | 26.57 | |
| Diluted earnings loss per share IFRS | CurrentYTDDuration | 35.16 | |
| Revenue IFRS | Prior1QuarterDuration | 10860144000 | JPY |
| Revenue IFRS | CurrentQuarterDuration | 13128651000 | JPY |
| Cost of sales IFRS | Prior1QuarterDuration | 6982543000 | JPY |
| Cost of sales IFRS | CurrentQuarterDuration | 8696636000 | JPY |
| Gross profit IFRS | Prior1QuarterDuration | 3877600000 | JPY |
| Gross profit IFRS | CurrentQuarterDuration | 4432015000 | JPY |
| Selling general and administrative expenses IFRS | Prior1QuarterDuration | 2825471000 | JPY |
| Selling general and administrative expenses IFRS | CurrentQuarterDuration | 3048599000 | JPY |
| Other income IFRS | Prior1QuarterDuration | 3170000 | JPY |
| Other income IFRS | CurrentQuarterDuration | 52000 | JPY |
| Other expenses IFRS | Prior1QuarterDuration | 36920000 | JPY |
| Other expenses IFRS | CurrentQuarterDuration | 34000 | JPY |
| Operating profit loss IFRS | Prior1QuarterDuration | 1018379000 | JPY |
| Operating profit loss IFRS | CurrentQuarterDuration | 1383434000 | JPY |
| Finance income IFRS | Prior1QuarterDuration | 11334000 | JPY |
| Finance income IFRS | CurrentQuarterDuration | 765000 | JPY |
| Finance costs IFRS | Prior1QuarterDuration | 23674000 | JPY |
| Finance costs IFRS | CurrentQuarterDuration | 19239000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1QuarterDuration | -1057000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentQuarterDuration | -1204000 | JPY |
| Profit loss before tax IFRS | Prior1QuarterDuration | 1004982000 | JPY |
| Profit loss before tax IFRS | CurrentQuarterDuration | 1363755000 | JPY |
| Income tax expense IFRS | Prior1QuarterDuration | 323017000 | JPY |
| Income tax expense IFRS | CurrentQuarterDuration | 414760000 | JPY |
| Profit loss IFRS | Prior1QuarterDuration | 681965000 | JPY |
| Profit loss IFRS | CurrentQuarterDuration | 948994000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1QuarterDuration | 561334000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentQuarterDuration | 850878000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1QuarterDuration | 120630000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentQuarterDuration | 98115000 | JPY |
| Basic earnings loss per share IFRS | Prior1QuarterDuration | 14.06 | |
| Basic earnings loss per share IFRS | CurrentQuarterDuration | 21.21 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |